Schwarz et al. — SmartAge randomized trial
No significant improvement in the primary memory outcome or secondary outcomes.
The record
- Year
- 2022
- Design
- Twelve-month randomized, double-masked, placebo-controlled trial
- Population
- 100 adults aged 60–90 with subjective cognitive decline
One wheat-germ preparation; exploratory signals require confirmation.